Metabolic effects of dialyzate glucose in chronic hemodialysis: Results from a prospective, randomized crossover trial

Nephrology Dialysis Transplantation

Volumn 27, Issue 4, 2012, Pages 1559-1568

  Raimann, Jochen G ^a,b   Kruse, Anja ^a,b,c   Thijssen, Stephan ^a,b   Kuntsevich, Viktoriya ^b   Dabel, Pascal ^b   Bachar, Mostafa ^d   Diaz Buxo, Jose A ^e   Levin, Nathan W ^a,b   Kotanko, Peter ^a,b  

^a RENAL RESEARCH INSTITUTE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

^e FRESENIUS MEDICAL CARE NORTH AMERICA   (United States)

Author keywords

diabetes mellitus; dialyzate; glucose; hemodialysis; insulin

Indexed keywords

DIALYSIS FLUID; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT; PHOSPHATE; POTASSIUM;

ADULT; ADVERSE OUTCOME; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; DIALYSATE LEVEL; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HEART VENTRICLE TACHYCARDIA; HEMODIALYSIS; HUMAN; HYPERGLYCEMIA; HYPERINSULINISM; HYPOGLYCEMIA; HYPOTENSION; INSULIN BLOOD LEVEL; LONG TERM CARE; MALE; METABOLIC REGULATION; OUTCOME ASSESSMENT; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPRAVENTRICULAR TACHYCARDIA; SYSTOLIC BLOOD PRESSURE; WEIGHT GAIN;

CROSS-OVER STUDIES; DIABETES MELLITUS; DIALYSIS SOLUTIONS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 84859373479     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr520     Document Type: Article

References (34)

1. Sharma R, Rosner MH. Glucose in the dialysate: historical perspective and possible implications? Hemodial Int 2008; 12: 221-226 (Pubitemid 351494275)
2. Burmeister JE, Scapini A, da Rosa Miltersteiner D et al. Glucoseadded dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis. Nephrol Dial Transplant 2007; 22: 1184-1189 (Pubitemid 46523436)
3. Fischbach M, Terzic J, Bitoun Cohen C et al. Glucose-charged dialysate for children on hemodialysis: acute dialytic changes. Pediatr Nephrol 1998; 12: 60-62 (Pubitemid 28165783)
4. Gutierrez A, Bergstrom J, Alvestrand A. Hemodialysis-associated protein catabolism with and without glucose in the dialysis fluid. Kidney Int 1994; 46: 814-822 (Pubitemid 24272040)
5. Ramirez G, Bercaw BL, Butcher DE et al. The role of glucose in hemodialysis: the effects of glucose-free dialysate. Am J Kidney Dis 1986; 7: 413-420 (Pubitemid 16019530)
6. Simic-Ogrizovic S, Backus G, Mayer A et al. The influence of different glucose concentrations in haemodialysis solutions on metabolism and blood pressure stability in diabetic patients. Int J Artif Organs 2001; 24: 863-869 (Pubitemid 34168374)
7. Jackson MA, Holland MR, Nicholas J et al. Hemodialysis-induced hypoglycemia in diabetic patients. Clin Nephrol 2000; 54: 30-34 (Pubitemid 30456802)
8. Jackson MA, Holland MR, Nicholas J et al. Occult hypoglycemia caused by hemodialysis. Clin Nephrol 1999; 51: 242-247 (Pubitemid 29196888)
9. Kooman J, Basci A, Pizzarelli F et al. EBPG guideline on haemodynamic instability. Nephrol Dial Transplant 2007; 22 (Suppl 2): ii22-ii44
10. Ward RA, Wathen RL, Williams TE et al. Hemodialysate composition and intradialytic metabolic, acid-base and potassium changes. Kidney Int 1987; 32: 129-135
11. Kemp GJ, Land JM, Coppack SW et al. Skeletal muscle phosphate uptake during euglycemic-hyperinsulinemic clamp. Clin Chem 1993; 39: 170-171 (Pubitemid 23034989)
12. Michaels AS. Operating parameters and performance criteria for hemodialyzers and other membrane-separation devices. Trans Am Soc Artif Intern Organs 1966; 12: 387-392
13. Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American diabetes association Workgroup on hypoglycemia. Diabetes Care.2005.28.1245-1249.
14. Schneditz D, Hafner-Giessauf H, Thomaseth K et al. Insulinogenic index in non-diabetics during haemodialysis. Nephrol Dial Transplant 2010; 25: 3365-3372
15. Abe M, Kikuchi F, Kaizu K et al. The influence of hemodialysis membranes on the plasma insulin level of diabetic patients on maintenance hemodialysis. Clin Nephrol 2008; 69: 354-360 (Pubitemid 351663170)
16. Abe M, Okada K, Ikeda K et al. Characterization of insulin adsorption behavior of dialyzer membranes used in hemodialysis. Artif Organs 2011; 35: 398-403
17. Waldhausl W, Bratusch-Marrain P, Gasic S et al. Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man. Diabetologia 1979; 17: 221-227 (Pubitemid 10189641)
18. Allegra V, Mengozzi G, Martimbianco L et al. Glucose-induced insulin secretion in uremia: effects of aminophylline infusion and glucose loads. Kidney Int 1990; 38: 1146-1150
19. DeFronzo RA, Alvestrand A. Glucose intolerance in uremia: site and mechanism. Am J Clin Nutr 1980; 33: 1438-1445 (Pubitemid 10013685)
20. Wathen RL, Keshaviah P, Hommeyer P et al. The metabolic effects of hemodialysis with and without glucose in the dialysate. Am J Clin Nutr 1978; 31: 1870-1875 (Pubitemid 9061152)
21. Dukkipati R, Kalantar-Zadeh K, Kopple JD. Is there a role for intradialytic parenteral nutrition? A review of the evidence. Am J Kidney Dis 2010; 55: 352-364
22. Ferrario M, Raimann JG, Thijssen S et al. Effects of dialysate glucose concentration on heart rate variability in chronic hemodialysis patients: results of a prospective randomized trial. Kidney Blood Press Res 2011; 34: 334-343
23. Coletta DK, Balas B, Chavez AO et al. Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo. Am J Physiol Endocrinol Metab 2008; 294: E910-E917
24. Malmberg K, Ryden L, Efendic S et al. Randomized trial of insulinglucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995; 26: 57-65
25. Malmberg K, Ryden L, Hamsten A et al. Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study. Cardiovasc Res 1997; 34: 248-253 (Pubitemid 27261936)
26. Malmberg K, Norhammar A, Wedel H et al. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99: 2626-2632 (Pubitemid 29237448)
27. Nordt TK, Klassen KJ, Schneider DJ et al. Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis. Arterioscler Thromb 1993; 13: 1822-1828 (Pubitemid 23360569)
28. Meigs JB, Mittleman MA, Nathan DM et al. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA 2000; 283: 221-228 (Pubitemid 30039222)
29. Esposito K, Nappo F, Marfella R et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002; 106: 2067-2072 (Pubitemid 35192812)
30. van Oostrom AJ, Sijmonsma TP, Verseyden C et al. Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res 2003; 44: 576-583 (Pubitemid 37279707)
31. Dandona P, Chaudhuri A, Ghanim H et al. Insulin as an antiinflammatory and antiatherogenic modulator. J Am Coll Cardiol 2009; 53: S14-S20
32. Dandona P, Chaudhuri A, Ghanim H et al. Anti-inflammatory effects of insulin and the pro-inflammatory effects of glucose. Semin Thorac Cardiovasc Surg 2006; 18: 293-301 (Pubitemid 46464512)
33. Vos FE, Manning PJ, Sutherland WH et al. Anti-inflammatory effect of an insulin infusion in patients on maintenance haemodialysis: a randomized controlled pilot study. Nephrology 2011; 16: 68-75
34. US Renal Data System. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009